Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Paediatric Anaesthesia|January 16, 2009
Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypassNina A Guzzetta, Shane Huch, Janet D Fernandez, et al.
Anesthesia and Analgesia|October 27, 2004
Fibrinogen in children undergoing cardiac surgery: is it effective?Bruce E Miller, Steven R Tosone, Nina A Guzzetta, et al.
Anesthesia and Analgesia|January 14, 2014
National pediatric anesthesia safety quality improvement program in the United StatesC Dean Kurth, Don Tyler, Eugenie Heitmiller, et al.
Anesthesia and Analgesia|April 23, 2005
An evaluation of the effects of a standard heparin dose on thrombin inhibition during cardiopulmonary bypass in neonatesNina A Guzzetta, Bruce E Miller, Kathy Todd, et al.
Anesthesia and Analgesia|January 30, 2008
A comparison of heparin management strategies in infants undergoing cardiopulmonary bypassNina A Guzzetta, Tanya Bajaj, Tom Fazlollah, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 3, 2004
The short term effects of cardiopulmonary bypass on neurologic function in children and young adultsWilliam T Mahle, Karen Lundine, Kirk R Kanter, et al.
Anesthesia and Analgesia|October 23, 2003
Tissue factor-activated thromboelastograms in children undergoing cardiac surgery: baseline values and comparisonsBruce E Miller, Nina A Guzzetta, Steven R Tosone, et al.
Anesthesia and Analgesia|October 24, 2006
Clinical measures of heparin's effect and thrombin inhibitor levels in pediatric patients with congenital heart diseaseNina A Guzzetta, Bruce E Miller, Kathy Todd, et al.
Anesthesia and Analgesia|January 20, 2009
The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysisNina A Guzzetta, Faye M Evans, Eli S Rosenberg, et al.
Pageof 1